Jedan od glavnih ciljeva Life4me+ — jeste da spreči nove slučajeve HIV-a i ostalih polno prenosivih infekcija, hepatitisa C i tuberkuloze.

Aplikacija pomaže da se uspostavi anonimna komunikacija između lekara i osoba koje žive sa HIV-om. Omogućava da lakše organizujete Vaš raspored upotrebe lekova i da postavite prikrivene i personalizovane podsetnike.

Nazad
31 јул 2017, 15:35
5661

The “An Application to Primary HIV Prevention Among High Risk Drug Users” Study

The “An Application to Primary HIV Prevention Among High Risk Drug Users” Study - slika 1

American researchers from Connecticut conducted a study called “An Application to Primary HIV Prevention Among High Risk Drug Users”, which was published in AIDS and behaviour journal.

To see how using of PrEP could protect people who use drugs, were selected more than 350 patients of methadone clinic with HIV negative status and with drug/sex risk behaviour. As the scientists report, the research was aimed to find the acceptability of PrEP based on a number of known PrEP attributes among high-risk people who use drugs  in a drug treatment setting. Patients were divided into 8 groups with different types PrEP dosage, cost and side effects. At the average PrEP shows 56% of efficiency. As the scientists concluded, their findings reported a high acceptability of PrEP in response to different PrEP program scenarios with different attribute profiles and this information can help to the other investigators and policymakers to optimize PrEP uptake among this underserved population.

Autor: Liliya Ten

Podeli na društvene mreže